Image: INSTI COVID-19 Antibody Test (Photo courtesy of INSTI COVID-19 Antibody Test)
A new one-minute antibody test for COVID-19 launched in Europe is the only test of its kind to use innovative flow-through technology to deliver results, making it far faster than other antibody tests currently available.
bioLytical Laboratories (Vancouver, BC, Canada) has launched INSTI COVID-19 Antibody Test, its new one-minute test that detects antibodies to SARS-CoV-2 with high accuracy, in Europe following the notification of CE mark and approval to sell the test across the region. The test detects total antibodies to SARS-CoV-2 and is the only one of its kind to use innovative flow-through technology to deliver results, making it far faster than other antibody tests currently available. The INSTI COVID-19 Antibody Test is completely portable, does not require additional equipment and can be performed in a multitude of settings with easy-to-interpret results. Test providers have the advantage of running more tests in less time, due to INSTI’s market-leading speed.
“Reliable and truly rapid antibody tests are an important part of our response to this global crisis,” said Robert Mackie, Chief Executive Officer. “The INSTI COVID-19 Antibody Test is a uniquely effective tool and distribution of our one-minute test kits around the globe is a critical step for tackling the spread of this virus.”